(Q43938205)

28 November 2017

title

Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient (English)

1 reference

28 November 2017

0 references

coagulation factor IX

0 references

0 references

1 reference

Priya Verghese

1

1 reference

28 November 2017

Stephen Darrow

2

1 reference

28 November 2017

Margaret H Kurth

3

1 reference

28 November 2017

Robyn C Reed

4

1 reference

28 November 2017

Youngki Kim

5

1 reference

28 November 2017

Susan Kearney

6

1 reference

28 November 2017

publication date

6 February 2013

1 reference

28 November 2017

1 reference

28 November 2017

volume

28

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

823-826

1 reference

Inhibitor development in haemophilia B: an orphan disease in need of attention

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Anaphylaxis in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

IgG subclasses and complement pathway in segmental and global membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Humoral theory of transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Rituximab for idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2397-0

Segmental membranous glomerulonephritis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23381011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The natural course of gold nephropathy: long term study of 21 patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23381011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nephrotic syndrome as a complication of immune tolerance in hemophilia B.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23381011

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00467-012-2397-0

1 reference

Dimensions Publication ID

28 November 2017

1004627972

0 references

1 reference